CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 161 filers reported holding CLOVIS ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $73,000 | -20.7% | 61,667 | +20.7% | 0.00% | – |
| Q2 2022 | $92,000 | +9.5% | 51,102 | +23.0% | 0.00% | – |
| Q1 2022 | $84,000 | -36.4% | 41,540 | -15.0% | 0.00% | -100.0% |
| Q4 2021 | $132,000 | -55.9% | 48,890 | -27.0% | 0.00% | 0.0% |
| Q3 2021 | $299,000 | -19.2% | 66,975 | +5.0% | 0.00% | -50.0% |
| Q2 2021 | $370,000 | +72.9% | 63,790 | +108.8% | 0.00% | +100.0% |
| Q1 2021 | $214,000 | +197.2% | 30,547 | +169.0% | 0.00% | 0.0% |
| Q1 2020 | $72,000 | – | 11,357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
| Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
| Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
| Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
| Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
| Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
| Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
| PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
| NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |